SARS

Scientists at the University of Cambridge and DIOSynVax have tested an AI-designed universal coronavirus vaccine in a Phase 1 trial involving 39 healthy volunteers, with results published in the Journ…

The University of Cambridge and spinout company DIOSynVax have successfully tested the first AI-designed universal coronavirus vaccine in humans, finding it safe and well-tolerated in a 39-volunteer t…